Protalix BioTherapeutics
PLX
#8915
Rank
NZ$0.24 B
Marketcap
NZ$3.00
Share price
-1.14%
Change (1 day)
3.50%
Change (1 year)

Protalix BioTherapeutics (PLX) - Net assets

Net assets on the balance sheet as of June 2025 : NZ$86.41 Million

According to Protalix BioTherapeutics 's latest financial reports the company has NZ$86.41 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Protalix BioTherapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$76.61 M44.34%
2023-12-31$NZ$53.08 M-416.75%
2022-12-31$-NZ$16.76 Million89.64%
2021-12-31$-NZ$8.84 Million-76.42%
2020-12-31$-NZ$37.48 Million-64.11%
2019-12-31$-NZ$0.11 Billion32.45%
2018-12-31$-NZ$78.84 Million90.07%
2017-12-31$-NZ$41.48 Million188.55%
2016-12-31$-NZ$14.38 Million-190.48%
2015-12-31$NZ$15.88 M-122.39%
2014-12-31$-NZ$70.97 Million116.41%
2013-12-31$-NZ$32.8 Million703.54%
2012-12-31$-NZ$4.09 Million-87.79%
2011-12-31$-NZ$33.42 Million127.65%
2010-12-31$-NZ$14.68 Million-167.12%
2009-12-31$NZ$21.86 M-71.38%
2008-12-31$NZ$76.41 M-8.09%
2007-12-31$NZ$83.14 M141.2%
2006-12-31$NZ$34.46 M286.55%
2005-12-31$NZ$8.91 M1185.45%
2004-12-31$NZ$0.69 M-31.2%
2003-12-31$NZ$1 M-33.72%
2002-12-31$NZ$1.52 M-33.22%
2001-12-31$NZ$2.27 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amicus Therapeutics
FOLD
NZ$0.39 B 361.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$5.20 B 5,918.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.21 B 186,453.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$12.56 B 14,436.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel